STOCK TITAN

[144] Inspire Medical Systems, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Inspire Medical Systems (INSP) filed a Form 144 notifying a proposed sale of 11,000 common shares through RBC Capital Markets on 08/29/2025 on the NYSE, with an aggregate market value of $1,027,349.00. The filing reports 29,574,316 shares outstanding, so the proposed block represents roughly 0.04% of outstanding shares. All 11,000 shares were acquired by option exercise between 06/30/2019 and 10/09/2020, totaling the same 11,000 shares listed for sale. No securities were sold by the filer in the past three months, and the filer certifies no undisclosed material adverse information.

Inspire Medical Systems (INSP) ha depositato un Modulo 144 notificando la proposta di vendita di 11.000 azioni ordinarie tramite RBC Capital Markets il 29/08/2025 sulla NYSE, per un valore di mercato complessivo di $1.027.349,00. Il deposito indica 29.574.316 azioni in circolazione, quindi il blocco proposto rappresenta circa il 0,04% del capitale sociale. Tutte le 11.000 azioni sono state acquisite tramite esercizio di opzioni tra il 30/06/2019 e il 09/10/2020, corrispondendo esattamente alle 11.000 azioni messe in vendita. Il dichiarante non ha venduto titoli negli ultimi tre mesi e certifica l'assenza di informazioni materiali negative non divulgate.

Inspire Medical Systems (INSP) presentó un Formulario 144 notificando la propuesta de venta de 11.000 acciones comunes a través de RBC Capital Markets el 29/08/2025 en la NYSE, con un valor de mercado agregado de $1,027,349.00. La presentación informa 29,574,316 acciones en circulación, por lo que el bloque propuesto representa aproximadamente el 0.04% de las acciones en circulación. Las 11.000 acciones fueron adquiridas mediante ejercicio de opciones entre el 30/06/2019 y el 09/10/2020, sumando exactamente las 11.000 acciones ofertadas. El declarante no vendió títulos en los últimos tres meses y certifica que no existe información material adversa no divulgada.

Inspire Medical Systems (INSP)는 NYSE에서 2025-08-29에 RBC Capital Markets를 통해 11,000 보통주 매도를 제안하는 Form 144를 제출했으며, 총 시가 가치는 $1,027,349.00입니다. 제출서에는 유통 주식 수가 29,574,316주로 기재되어 있어 제안된 블록은 대략 전체의 0.04%에 해당합니다. 이 11,000주 전부는 옵션 행사로 2019-06-30부터 2020-10-09 사이에 취득된 것으로, 매도 예정인 11,000주와 정확히 일치합니다. 제출인은 지난 3개월 동안 증권을 매각하지 않았으며, 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.

Inspire Medical Systems (INSP) a déposé un formulaire 144 informant d'une proposition de vente de 11 000 actions ordinaires via RBC Capital Markets le 29/08/2025 à la NYSE, pour une valeur de marché totale de $1,027,349.00. Le dépôt indique 29,574,316 actions en circulation, de sorte que le bloc proposé représente environ 0,04% des actions en circulation. Les 11 000 actions ont été acquises par exercice d'options entre le 30/06/2019 et le 09/10/2020, correspondant exactement aux 11 000 actions mises en vente. Le déclarant n'a pas vendu de titres au cours des trois derniers mois et certifie qu'il n'existe pas d'informations défavorables matérielles non divulguées.

Inspire Medical Systems (INSP) hat ein Formular 144 eingereicht und den geplanten Verkauf von 11.000 Stammaktien über RBC Capital Markets zum 29.08.2025 an der NYSE mit einem Gesamtmarktwert von $1.027.349,00 gemeldet. Die Einreichung gibt 29.574.316 ausstehende Aktien an, sodass das vorgeschlagene Paket etwa 0,04% der ausstehenden Aktien ausmacht. Alle 11.000 Aktien wurden durch Optionsausübung zwischen dem 30.06.2019 und dem 09.10.2020 erworben und entsprechen genau den zum Verkauf stehenden 11.000 Aktien. Der Meldende hat in den letzten drei Monaten keine Wertpapiere verkauft und bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen.

Positive
  • None.
Negative
  • None.

Insights

Routine insider sale notice; small volume relative to float, limited market impact.

The Form 144 documents a proposed sale of 11,000 common shares valued at about $1.03 million, executed through a broker on a specified date. The shares were acquired via option exercises from 2019–2020, indicating these are previously granted equity awards being monetized rather than new dilution. At ~0.04% of outstanding shares, the position is immaterial to the company capitalization and unlikely to affect market liquidity or share price materially.

Disclosure aligns with Rule 144 requirements; signer affirms absence of undisclosed material information.

The filing contains the required seller representations and acquisition history supporting compliance with Rule 144 resale conditions. The absence of sales in the prior three months and the statement that the filer is unaware of undisclosed material adverse information reduce governance concerns. This is a standard liquidity event for an insider who exercised options previously.

Inspire Medical Systems (INSP) ha depositato un Modulo 144 notificando la proposta di vendita di 11.000 azioni ordinarie tramite RBC Capital Markets il 29/08/2025 sulla NYSE, per un valore di mercato complessivo di $1.027.349,00. Il deposito indica 29.574.316 azioni in circolazione, quindi il blocco proposto rappresenta circa il 0,04% del capitale sociale. Tutte le 11.000 azioni sono state acquisite tramite esercizio di opzioni tra il 30/06/2019 e il 09/10/2020, corrispondendo esattamente alle 11.000 azioni messe in vendita. Il dichiarante non ha venduto titoli negli ultimi tre mesi e certifica l'assenza di informazioni materiali negative non divulgate.

Inspire Medical Systems (INSP) presentó un Formulario 144 notificando la propuesta de venta de 11.000 acciones comunes a través de RBC Capital Markets el 29/08/2025 en la NYSE, con un valor de mercado agregado de $1,027,349.00. La presentación informa 29,574,316 acciones en circulación, por lo que el bloque propuesto representa aproximadamente el 0.04% de las acciones en circulación. Las 11.000 acciones fueron adquiridas mediante ejercicio de opciones entre el 30/06/2019 y el 09/10/2020, sumando exactamente las 11.000 acciones ofertadas. El declarante no vendió títulos en los últimos tres meses y certifica que no existe información material adversa no divulgada.

Inspire Medical Systems (INSP)는 NYSE에서 2025-08-29에 RBC Capital Markets를 통해 11,000 보통주 매도를 제안하는 Form 144를 제출했으며, 총 시가 가치는 $1,027,349.00입니다. 제출서에는 유통 주식 수가 29,574,316주로 기재되어 있어 제안된 블록은 대략 전체의 0.04%에 해당합니다. 이 11,000주 전부는 옵션 행사로 2019-06-30부터 2020-10-09 사이에 취득된 것으로, 매도 예정인 11,000주와 정확히 일치합니다. 제출인은 지난 3개월 동안 증권을 매각하지 않았으며, 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.

Inspire Medical Systems (INSP) a déposé un formulaire 144 informant d'une proposition de vente de 11 000 actions ordinaires via RBC Capital Markets le 29/08/2025 à la NYSE, pour une valeur de marché totale de $1,027,349.00. Le dépôt indique 29,574,316 actions en circulation, de sorte que le bloc proposé représente environ 0,04% des actions en circulation. Les 11 000 actions ont été acquises par exercice d'options entre le 30/06/2019 et le 09/10/2020, correspondant exactement aux 11 000 actions mises en vente. Le déclarant n'a pas vendu de titres au cours des trois derniers mois et certifie qu'il n'existe pas d'informations défavorables matérielles non divulguées.

Inspire Medical Systems (INSP) hat ein Formular 144 eingereicht und den geplanten Verkauf von 11.000 Stammaktien über RBC Capital Markets zum 29.08.2025 an der NYSE mit einem Gesamtmarktwert von $1.027.349,00 gemeldet. Die Einreichung gibt 29.574.316 ausstehende Aktien an, sodass das vorgeschlagene Paket etwa 0,04% der ausstehenden Aktien ausmacht. Alle 11.000 Aktien wurden durch Optionsausübung zwischen dem 30.06.2019 und dem 09.10.2020 erworben und entsprechen genau den zum Verkauf stehenden 11.000 Aktien. Der Meldende hat in den letzten drei Monaten keine Wertpapiere verkauft und bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

2.73B
26.84M
1.17%
117.78%
8.49%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY